Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 9.85x is 109% above its 5-year average of -104.18x, near the high end of its 5-year range (-3431.83x–98.98x).
As of the fiscal period ended Tuesday, June 30, 2026. 253.43% above its 12-month average of -6.42x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-06-30): 9.85x.
INTEREST COVERAGE RATIO
9.85x
INTEREST COVERAGE RATIO AVG TTM
-6.42x
INTEREST COVERAGE RATIO AVG 3Y
-112.24x
INTEREST COVERAGE RATIO AVG 5Y
-104.18x
INTEREST COVERAGE RATIO AVG 10Y
-41.09x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+253.43%
CURRENT VS 3Y AVG
+108.77%
CURRENT VS 5Y AVG
+109.45%
CURRENT VS 10Y AVG
+123.97%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
+270.08%
vs the sector median at left
Organigram Global Inc.
Market Cap
$134.44M
Interest Coverage Ratio
9.85x
TTM Avg
-6.42x
3Y Avg
-112.24x
5Y Avg
-104.18x
Market Cap
$133.38M
Interest Coverage Ratio
-2.20x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$135.80M
Interest Coverage Ratio
-0.80x
TTM Avg
1.46x
3Y Avg
2.93x
5Y Avg
2.25x
Market Cap
$135.98M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$132.10M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$137.17M
Interest Coverage Ratio
N/A
TTM Avg
346.24x
3Y Avg
936.28x
5Y Avg
577.46x
Market Cap
$139.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Organigram Global Inc. (OGI) | $134.44M | 9.85x | -6.42x | -112.24x | -104.18x |
| Freenome, Inc. (FRNM)vs › | $135.49M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $133.38M | -2.20x | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $133.48M | -5.64x | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $135.80M | -0.80x | 1.46x | 2.93x | 2.25x |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.98M | N/A | N/A | N/A | N/A |
| Pyxis Oncology, Inc. (PYXS)vs › | $132.10M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.17M | N/A | 346.24x | 936.28x | 577.46x |
| Alpha Cognition Inc (ACOG)vs › | $139.01M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | -8.06x | N/A | N/A | N/A |
Interest Coverage
9.8x
Debt/Equity
0.04
Current Ratio
2.61
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 9.85x |
| 2025-09-30 | -22.68x |
| 2025-03-31 | 60.97x |
| 2024-12-31 | 11.86x |
| 2024-06-30 | -97.08x |
| 2024-03-31 | -233.03x |
| 2023-12-31 | -331.85x |
| 2023-09-30 | -295.95x |
| 2023-05-31 | -3431.83x |
| 2023-02-28 | -172.11x |
| 2022-11-30 | 98.98x |
| 2022-08-31 | -50.83x |
| 2022-05-31 | -135.66x |
| 2022-02-28 | -77.22x |
| 2021-11-30 | -165.34x |
| 2021-08-31 | -162.65x |
| 2021-05-31 | -28.02x |
| 2021-02-28 | -36.59x |
| 2020-11-30 | -17.77x |
| 2020-08-31 | -44.28x |
| 2020-05-31 | -44.69x |
| 2020-02-29 | -2.05x |
| 2019-11-30 | 0.18x |
| 2019-08-31 | -35.29x |
| 2019-05-31 | -29.78x |
| 2019-02-28 | -0.41x |
| 2018-11-30 | 11.04x |
| 2018-08-31 | 6.69x |
| 2018-05-31 | 1.82x |
| 2018-02-28 | 1.63x |
| 2017-11-30 | -25.04x |
| 2017-08-31 | -35.70x |
| 2017-05-31 | -48.16x |
| 2017-02-28 | -93.49x |
| 2016-11-30 | -7.12x |
| 2016-08-31 | 6.05x |
| 2016-05-31 | 3.96x |
| 2016-02-29 | 1.46x |
| 2015-11-30 | -1.61x |
| 2015-08-31 | 2.17x |
| 2015-05-31 | 4.14x |
| 2015-02-28 | -21.21x |
| 2013-10-31 | -0.08x |
